# Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical Patients

> **NCT00934167** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Azidus Brasil** · enrollment: 140 (estimated)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **BIOLOGICAL:** heparin sodium - Hipolabor
- **BIOLOGICAL:** Heparin sodium - APP

## Key facts

- **NCT ID:** NCT00934167
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2010-11
- **Final completion:** 2011-09
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2010-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00934167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00934167, "Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00934167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*